July 15th 2025
Robert Kratzke, MD, urged insurance providers to prioritize fast biomarker testing in non–small cell lung cancer, saying it’s both cost-effective and life-saving.
Ross Owen Outlines the Importance of Local Partnerships When Caring for Complex Populations
March 19th 2017Partnering with local nonprofits with expertise in various areas, such as food support, vocational services, and mental health case management, Hennepin Health has been able to successful manage the health of a complex population, explained Ross Owen, health strategy director of Hennepin County.
Watch
Home Visit Models Save Money, Reduce ED Visits, Hospitalizations
March 17th 2017Home visits by teams led by registered nurses or lay health workers can reduce costs and utilization of services, such as emergency department visits and hospitalizations, according to a paper published in Health Affairs.
Read More
Medicare claims analyses offer insight into how proposed policy changes would affect out-of-pocket prescription costs for Part D beneficiaries requiring specialty drugs.
Read More
Dr Marietou Ouayogode: More Emphasis on Prevention Is Important for Baby Boomers
March 17th 2017The increased emphasis that the Affordable Care Act and Medicare accountable care organizations (ACOs) placed on prevention is important in reducing the high cost of older patients, especially as the baby boomer generation reached retirement age, explained Mariétou Ouayogodé, PhD, post-doctoral fellow at The Dartmouth Institute for Health Policy and Clinical Practice at the Geisel School of Medicine at Dartmouth.
Watch
Beneficiary Engagement in Medicare's Alternative Payment Models: From Serendipity to Active Choice
March 10th 2017This article explores elements of patient and consumer engagement implicated by Medicare’s alternative payment models, emphasizing the potential for shopping and use of cost information.
Read More
Dr Roy Beveridge Discusses Humana's Efforts to Include Perspective of Patient and Provider
March 10th 2017The main focus of Humana’s business activities is to provide a better experience for patients and physicians, according to Roy Beveridge, MD, chief medical officer of Humana. This patient-centered approach is informed by his work as a practicing oncologist, where he learned to think about clinical programs from the perspective of the patient.
Watch
Part D Subsidies Can Help Reduce Racial Disparities in Breast Cancer Treatment Persistence
March 6th 2017A recent study has found that low-income subsidies under the Medicare Part D program can help improve rates of persistence and adherence to breast cancer therapies among Hispanic and black women.
Read More
5 Takeaways From the PAN Foundation's Cost-Sharing Roundtable
March 3rd 2017The roundtable provides a forum for academic researchers, health policy experts, patient advocates, health insurance plans, and the pharmaceutical industry to debate on the most sustainable strategies for patient cost sharing for medications.
Read More
Reducing Out-of-Pocket Cost Barriers to Specialty Drug Use Under Medicare Part D
March 1st 2017Research presented by Jalpa A. Doshi, PhD, associate professor of medicine, director, Economic Evaluations Unit, Center for Evidence-based Practice, and director, Value-based Insurance Design Initiatives, Center for Health Incentives and Behavioral Economics, University of Pennsylvania, the Cost-Sharing Roundtable: Sustainable Strategies for Providing Access to Critical Medications. The event was co-hosted by the PAN Foundation and The American Journal of Managed Care®.
Watch
The Uncertain Future of High-Need Medicare Beneficiaries
February 27th 2017At the 2nd cost-sharing roundtable hosted by the Patient Access Network Foundation and The American Journal of Managed Care®, Tricia Neuman of the Kaiser Family Foundation provided a perspective on what the future might hold for patients enrolled in Medicare.
Read More
Pharma—PBM War on Drug Prices Picks Up Steam
February 17th 2017An e-mail, from Mark Merritt, president and CEO of the trade group Pharmaceutical Care Management Association, to the organization’s board, lays out a plan to develop an aggressive campaign to convince the new administration that the fault rests with pharmaceutical manufacturers.
Read More
PhRMA Takes Aim at IPAB, a Longtime Target
February 13th 2017Lawmakers from both parties have expressed their dislike for an entity that could take away their spending authority. But a leading Democrat also raised the fact that the new HHS Secretary, Tom Price, MD, would be harsh on the most vulnerable.
Read More
Tom Price Is Confirmed as HHS Secretary, Will Lead ACA Repeal
February 10th 2017Early in the morning on Friday, the Senate voted along party lines (52-47) to confirm US Rep. Tom Price, R-Georgia, as secretary of HHS. President Donald Trump nominated Price with the expectation that he will lead the charge to repeal and replace the Affordable Care Act.
Read More